Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled study of SLITone in house dust mite-allergic asthma
2005-004731-21Phase 4Completed
- Sponsor
- ALK-Abelló
- Start
- Nov 2005
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, double-blind trial of SLITone Dermatophagoides mezcla in allergic asthma and house dust mite allergy (2 arms), sponsored by ALK-Abelló. Started Nov 2005; status: completed.
02
Drugs
SLITone Dermatophagoides mezcla
03
Conditions
allergic asthmahouse dust mite allergy
Beyond the preview
Go deeper on 2005-004731-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004731-21.